Large-scale testing (Phase 3)Study completedNCT04494438What this trial is testingRituximab for Idiopathic Nephrotic SyndromeWho this might be right forIdiopathic Nephrotic Syndrome Istituto Giannina Gaslini 30
Testing effectiveness (Phase 2)WithdrawnNCT05599815What this trial is testingPart 1 - A Clinical Trial in Patients With Frequently Relapsing and Steroid-Dependent Nephrotic SyndromeWho this might be right forNephrotic Syndrome Aldeyra Therapeutics, Inc.
Not applicableActive Not RecruitingNCT02194582What this trial is testingGenetic Causes of FSGS, Nephrotic Syndrome, or Kidney FailureWho this might be right forFocal Segmental GlomerulosclerosisNephrotic SyndromeEnd Stage Renal Disease+2 more Beth Israel Deaconess Medical Center 2,050
Testing effectiveness (Phase 2)Study completedNCT04783675What this trial is testingEfficacy and Safety of Rituximab in the First Episode of Pediatric Idiopathic Nephrotic SyndromeWho this might be right forSteroid-Sensitive Nephrotic Syndrome Children's Hospital of Fudan University 44
Not applicableLooking for participantsNCT05505500What this trial is testingInterview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.Who this might be right forFluid OverloadGlomerulosclerosis, Focal SegmentalEdema+10 more University of Michigan 150
Not applicableNot Yet RecruitingNCT07010250What this trial is testingEpithelial Dysmetabolism and Renal Fibrosis in ANCA VasculitisWho this might be right forANCA Associated VasculitisExtramembranous GlomerulopathyNephrotic Syndrome, Minimal Change+4 more Assistance Publique - Hôpitaux de Paris 146
Testing effectiveness (Phase 2)Study completedNCT02592798What this trial is testingPilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)Who this might be right forNephrotic SyndromeFocal Segmental GlomerulosclerosisMinimal Change Disease Bristol-Myers Squibb 36
Testing effectiveness (Phase 2)Looking for participantsNCT06466135What this trial is testingStudy of WAL0921 in Patients With Glomerular Kidney DiseasesWho this might be right forDiabetic NephropathiesPrimary Focal Segmental GlomerulosclerosisMinimal Change Disease+2 more Walden Biosciences 96
Testing effectiveness (Phase 2)Looking for participantsNCT06500702What this trial is testingEvaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change DiseaseWho this might be right forFocal Segmental GlomerulosclerosisGlomerulonephritis Minimal Lesion Sanofi 84
Large-scale testing (Phase 3)UnknownNCT03501459What this trial is testingLymphocyte Markers As Predictors Of Responsiveness To Rituximab Among Patients With Idiopathic Nephrotic SyndromeWho this might be right forNephrotic Syndrome National University Health System, Singapore 100
Not applicableLooking for participantsNCT04571658What this trial is testingNEPTUNE Match StudyWho this might be right forNephrotic Syndrome in ChildrenFocal Segmental GlomerulosclerosisMinimal Change Disease+6 more University of Michigan 375
Post-approval studies (Phase 4)Study completedNCT01185197What this trial is testingMyfortic® for Minimal Change Nephrotic Syndrome (MCNS): a Randomized StudyWho this might be right forNephrosis, Lipoid The University of Hong Kong 20
Not applicableStudy completedNCT05712369What this trial is testingB Cells in Idiopathic Nephrotic SyndromeWho this might be right forNephrotic Syndrome Mario Negri Institute for Pharmacological Research 21
Not applicableLooking for participantsNCT04207580What this trial is testingA National Prospective Cohort of Patients With Idiopathic Nephrotic Syndrome Beginning in Childhood.Who this might be right forIdiopathic Nephrotic Syndrome University Hospital, Limoges 1,180
Not applicableNot Yet RecruitingNCT06443034What this trial is testingPredictive Determinants of Nephrotic Syndrome Remission in Patients With At-risk Polymorphism of APOL1Who this might be right forNephrotic SyndromeFocal Segmental GlomerulosclerosisAPOL1 Associated Kidney Disease Assistance Publique - Hôpitaux de Paris 124
Not applicableStudy completedNCT01616446What this trial is testingPharmacokinetics of Cyclosporin in Nephrotic SyndromeWho this might be right forNephrotic Syndrome University of Sao Paulo 10
Not applicableUnknownNCT03786263What this trial is testingCHILDNEPH The Canadian Childhood Nephrotic Syndrome StudyWho this might be right forNephrotic Syndrome in ChildrenNephrotic Syndrome, Minimal ChangeNephrotic Syndrome，Idiopathic University of Calgary 400
Large-scale testing (Phase 3)Study completedNCT01268033What this trial is testingEfficacy of Rituximab For the Treatment of Calcineurin Inhibitors Dependent Nephrotic Syndrome During ChildhoodWho this might be right forChildhood Idiopathic Nephrotic Syndrome University Hospital, Limoges 26
Not applicableStudy completedNCT04818723What this trial is testingRole of Montelukast in Preventing Relapse in Childhood Idiopathic Nephrotic SyndromeWho this might be right forNephrotic Syndrome Nishtar Medical University 106
Not applicableLooking for participantsNCT03929887What this trial is testingKOrea Renal Biobank NEtwoRk System TOward NExt-generation AnalysisWho this might be right forGlomerular DiseaseMinimal Change DiseaseIgA Nephropathy+4 more Seoul National University Hospital 3,000